Benefits

What EryonOne helps prepare

Therapeutic or comparative claims

Spot wording to secure, comparisons to document and passages that need regulatory or medical validation.

Consistency with references

Compare the asset with provided documents such as SmPC, MA, opinions or bibliography to identify discrepancies to examine.

Benefit / risk balance

Flag areas where benefits, limits, precautions or important mentions seem insufficiently visible.

Use cases

Use cases

  • Pharmaceutical companies preparing an internal review.
  • Healthcare agencies adapting content to the French market.
  • International teams wanting to structure marketing, medical and regulatory exchanges.

Limits

An assistant, not a regulatory authorisation

EryonOne is an assistant, not a validator. Business responsibility (regulatory, medical, quality, legal) stays with your teams. The report is working material, not an approval.

Frequently asked questions

FAQ

Does EryonOne deliver an ANSM approval?

No. EryonOne helps prepare the review of an asset, but replaces neither the competent authority nor internal regulatory validation.

Which promotional materials can be reviewed?

For now, review is available on PDF. Word and PowerPoint come next. Detail aids, brochures, e-mailings, web pages, presentations, product sheets or scripts must therefore be provided as PDF.

Can the tool compare an asset with the SmPC or MA?

Yes, if the reference documents are provided. EryonOne helps spot discrepancies or points to arbitrate.

Who makes the final decision?

Regulatory, medical or legal teams always keep the final say.

Next step

Frame a first review

Describe your material, your market and your internal approval circuit. Demo and quote requests go through the contact form.

More about EryonOne